LD-2 disclosure · 4th Quarter - Report
BLUEBIRD BIO
Client
- Name
- BLUEBIRD BIO
- Description
- Clinical-stage company developing gene therapies for severe genetic and rare diseases.
- Location
- District of Columbia · United States of America
Registrant
- Description
- Consulting firm.
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
2 issuesMedicare/Medicaid
S. 2543 Prescription Drug Pricing Act and issues related to value based payment over time; H.R. 5882 Gene Therapy Payment Act; H.R. 3935, the Protecting Patients Transportation to Care Act; issues related to the Notice of Proposed rulemaking supporting VBP Arrangement; monitored issues related to H.R. 133, the Consolidated Appropriations Act of 2021; monitored issues related to the Most Favored Nation (MFN) rule.
LobbyistsSTACEY HUGHES · EMILY PORTER
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS) · Food & Drug Administration (FDA)
Health Issues
Issues related to FDA approval of breakthrough therapies.
LobbyistsSTACEY HUGHES · EMILY PORTER
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS) · Food & Drug Administration (FDA)